Biomarin Pharmaceutical Inc. BMRN
$55.19
▲ +0.74% 24H
About
BioMarin Pharmaceutical Inc. is a leading global biotechnology company specializing in the development and commercialization of therapies for people with serious and life-threatening rare genetic diseases. Its portfolio includes eight approved treatments targeting conditions such as mucopolysaccharidosis types I, IVA, …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees3,221
TickerBMRN
Statistics
Market Cap$10.67B
Revenue (TTM)$3.22B
Net Income$348.9M
Net Margin10.8%
EPS$1.80
P/E39.96
P/S3.31
P/B1.73
EV/EBITDA15.96
ROE4.5%
Dividend Yield—
Price$55.19
Data: Twelve Data · Revenue = mcap / P/S